AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04132622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levothyroxine Sodium
Description: Levothyroxine Sodium Tablets (50 ug, calculated by Levothyroxine Sodium ), produced by Merck KGaA, Darmstadt.
Study NCT04132622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Traditional therapy
Description: including steroids, vitamin C, hemodialysis and blood perfusion.
Study NCT00634387 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Anthocyans
Description: Anthocyans
Study NCT00634387 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Anthocyans
Description: Anthocyans
Study NCT03157544 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: multimodal non-pharmacological Pain Relief Kit
Description: Participants will be told: No two people have the same kind of pain and that pain management must be individualized to your pain. Thus, we want you to try the four modes of the non-pharmacological interventions included in the kit individually and in combination in order to determine what works best to relieve your pain~The Pain Relief kit will also include written instructions and materials for three behavioral techniques directed at maintaining compliance with the non-pharmacological interventions. During the review of the Pain Relief Kit with a member of the research staff participants will be informed about the recommended use of the three behavioral techniques including setting goals, working with a buddy and keeping a graph of your progress. This information will also be included in written form in the Pain Relief Kit.
Study NCT02251743 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurofeedback treatment
Description: Each session, the child participates in 5 training tasks. Each task lasts 5 minutes at the beginning and gradually increases to 9 minutes per task over the course of the neurofeedback as the child's attention span improves. We record four results for each of the 5 tasks:~1. The number of half-second periods that they met the reward parameters (i.e. theta mV below threshold; beta mV above threshold)~2. Average voltage of theta waves~3. Average voltage of beta~4. Average ratio of theta to beta power (TBR)
Study NCT02251743 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Neurofeedback treatment
Description: Each session, the child participates in 5 training tasks. Each task lasts 5 minutes at the beginning and gradually increases to 9 minutes per task over the course of the neurofeedback as the child's attention span improves. We record four results for each of the 5 tasks:~1. The number of half-second periods that they met the reward parameters (i.e. theta mV below threshold; beta mV above threshold)~2. Average voltage of theta waves~3. Average voltage of beta~4. Average ratio of theta to beta power (TBR)
Study NCT00937235 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Varenicline
Description: 1 mg tablets, orally, twice daily x 12 weeks
Study NCT00937235 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Varenicline
Description: 1 mg tablets, orally, twice daily x 12 weeks
Study NCT00937235 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medication Management Counseling
Description: 15-minutes weekly counseling x 12 weeks, focused on medication adherence and smoking cessation
Study NCT00937235 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Medication Management Counseling
Description: 15-minutes weekly counseling x 12 weeks, focused on medication adherence and smoking cessation
Study NCT00937235 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure
Description: 75-90 minute weekly psychotherapy sessions x 12 weeks, focused on gradually confronting distressing trauma-related memories and reminders
Study NCT01538771 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Darbepoetin alfa
Description: Darbepoetin alfa 300ug intracoronary bolus infusion via over-the-wire balloon before the 1st ballooning and conventional treatment
Study NCT01538771 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Control Saline
Description: Same volume of saline intracoronary bolus infusion via over-the-wire balloon before the 1st ballooning and conventional treatment
Study NCT04132622 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Traditional therapy
Description: including steroids, vitamin C, hemodialysis and blood perfusion.
Study NCT02655679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VTP-38543
Description: VTP-38543 topical cream
Study NCT02655679 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle with Transcutol®P
Description: Vehicle matching VTP-38543 cream with Transcutol®P
Study NCT00980083 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Study NCT00980083 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Exendin(9-39)amide
Study NCT02108457 — intervention group
Intervention type: RADIATION
Intervention: [18F]Fluorothymidine (FLT) PET/CT Imaging
Study NCT04264104 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: neural mobilization
Description: This is a type of mobilization that uses a specific combination of joint movements
Study NCT04264104 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: neural mobilization
Description: This is a type of mobilization that uses a specific combination of joint movements
Study NCT02353949 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flutemetamol (Vizamyl)
Description: PET-MR Scan using the radiotracer Flutemetamol (Vizamyl) for diagnostic purpose
Study NCT02125994 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Interscalene nerve block
Study NCT05307471 — intervention group
Intervention type: OTHER
Intervention: Thoracotomy/scopy
Study NCT04377529 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Local Champion
Description: Local champions (physiotherapists) will co-develop the champion training support based on a comprehensive behavioural analysis, previous implementation work and evidence-based theory. The study team will provide this training and support to the champions, who will then provide additional support to their peers participating in the study.
Study NCT04377529 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Local Champion
Description: Local champions (physiotherapists) will co-develop the champion training support based on a comprehensive behavioural analysis, previous implementation work and evidence-based theory. The study team will provide this training and support to the champions, who will then provide additional support to their peers participating in the study.
Study NCT02592564 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavior therapy
Description: Internet-delivered cognitive behavior therapy for social anxiety disorder. Similar to previous studies in our research group, the treatment will be delivered during 9 weeks. Each week the participant will be introduced to a module containing text material and homework assignments. The participants will receive feedback via text by a clinical psychologist once a week.
Study NCT03149835 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation
Description: NIV was provided by BiPAP-Vision™ ventilator (Philips Respironics Inc, Murrysville, PA, USA) set at the BIPAP mode and applied by a nasal mask, with room air, for 60 minutes. Volunteers were studied during the application of NIV (inspiratory pressure of 14cmH2O and expiratory pressure of 4cmH2O), with a pressure support of 10cmH2O and without oxygen support (FIO2 0.21). These pressure levels were chosen based on the current practice of NIV in the intensive care setting.
Study NCT00634387 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study NCT00634387 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Anthocyans
Study NCT03050684 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: vaginal lavage group
Description: vaginal washing will be applied with steril %0.9 NaCl serum (20cc) before intravaginal PGE2 insertion.
Study NCT02655679 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle without Transcutol®P
Description: Vehicle matching VTP-38543 cream without Transcutol®P
Study NCT01096433 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CPAP treatment
Description: maintains upper airway patency and minimizes the obstructive events
Study NCT01842750 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endorectal Balloon insertion
Study NCT01564238 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Na diet (1.3 g/d)
Description: 20 day controlled feeding study (live in) providing 1.3 grams per day of sodium.
Study NCT01564238 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High sodium diet (3.8 g/d)
Description: 20 day controlled feeding study (live in) providing 3.8 grams per day of sodium.
Study NCT00043394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.04 mg/kg CpG 7909
Description: 0.04 mg/kg CpG 7909 by subcutaneous Injection once weekly until progression or 24 weeks
Study NCT00043394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Herceptin®
Description: Herceptin® (maintenance dose per the manufacturer's directions) followed by a subcutaneous injection of CpG 7909.
Study NCT00043394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.08 mg/kg CpG 7909
Description: 0.08 mg/kg CpG 7909 by subcutaneous Injection once weekly until progression or 24 weeks
Study NCT00043394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.12 mg/kg CpG 7909
Description: 0.12 mg/kg CpG 7909 by subcutaneous Injection once weekly until progression or 24 weeks
Study NCT00043394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.16 mg/kg CpG 7909
Description: 0.16 mg/kg CpG 7909 by subcutaneous Injection once weekly until progression or 24 weeks
Study NCT03038685 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strokecoach.be - digital coaching program for stroke patients
Description: The stroke coach gives patients two education sessions during hospitalization (risk factor management, review of medications and clinical evolution). During these sessions, study participation will be proposed. Eligibility will partially depend on their historical use of the internet and e-mail. The aim is to have the digital platform personalized for his/her individual needs, risk factors and remaining neurologic signs/symptoms. Tips and tricks to deal with lifestyle modification will be delivered on regular basis. Meanwhile, patients will be asked to complete on a pre-specified frequency their data regarding their cardiovascular risk profile. Additionally, participants will be contacted at 0.5-1-2 and 6 months by phone calls or videoconsultancy. To standardize, an adapted, digital version of the standardized WSO Post-Stroke Checklist shall be used as a decision-support flowchart. A report of the consultation will be derived after the videoconsultancy.
Study NCT01413932 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HT-2157
Description: QD oral dosing
Study NCT01413932 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: QD oral dosing
Study NCT02933229 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: biopsy
Description: patients enrolled in the study will receive gastroscopy and biopsies in order to evaluate status of pathology.
Study NCT02933229 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H. pylori eradication
Description: H. pylori eradication therapy comprising esomeprazole, amoxicillin,clarithromycin and colloidal bismuth pectin.~If failed in eradicating H. pylori, a culture based antimicrobial susceptibility test will be used to guide H. pylori eradication.
Study NCT02407145 — intervention group
Intervention type: OTHER
Intervention: 24 month follow up of women with validated questionnaire
Description: 24 month follow up (clinical and questionnaire based) of women who are already assigned to have a PVDF retropubic midurethral sling (DynaMesh®-SIS soft) as a part of their planned treatment of urodynamic stress incontinence.
Study NCT05761535 — intervention group
Intervention type: RADIATION
Intervention: Magnetic Resonance (MR) and positron emission tomograph (PET) imaging analyses
Description: Regarding the neurological MR protocol, the following may be acquired:~* 3D T1 and T2 high-resolution sequences, acquired in a specific plane and Multiplanar reformation (MPR) reconstructed in the remaining orthogonal planes, for morphological assessment of the different structures under examination;~* diffusion sequences for the evaluation of the connection between different areas within a specific organ;~* perfusion sequences (ASL, arterial spin labeling) for the evaluation of perfusion without ev mdc administration;~* susceptibility sequences for noninvasive assessment of vasculature and deposits of iron.
Study NCT02080702 — intervention group
Intervention type: DEVICE
Intervention: Monosyn
Description: Monosyn will be used to perform the gastrointestinal anastomoses
Study NCT04161339 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Description: 400mg/daily of hydroxychloroquine for 8 weeks
Study NCT04161339 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: Amido pills/daily for 8 weeks
Study NCT04519606 — intervention group
Intervention type: PROCEDURE
Intervention: Optimal lung compliance during OLV
Description: Stepwise increase of tidal volume from 4 ml/kg PBW to 7 ml/kg PBW during OLV to determine the optimal tidal volume at the level the the pressure-volume loop reaches upper refection point where the peak airway pressure at or just below 30 cmH2O
Study NCT03815045 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Landmark-based lumbar puncture
Description: Traditional landmark based lumbar puncture involves palpating spinous processes on the back and finding the inter-spinous space which is the site of needle entry to gain access to the thecal sac. Finding this space may be difficult by palpation, especially when subjects undergoing the procedure are obese, elderly, have had prior back surgery, or if the patient is positioned incorrectly.
Study NCT03815045 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound-guided lumbar puncture
Description: Ultrasound guided lumbar puncture is a novel technique being increasingly utilized by emergency physicians, pediatricians and anesthesiologists. In this technique, an ultrasound probe is used to visualize the inter-spinous space. This space can be marked on the skin as the potential point of entry. This could potentially make it easier when patient factors make it difficult to palpate and find the site of entry.
Study NCT03346356 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Teenagers as cross-age SHCP teachers for younger youth
Description: Implementation of the SHCP using teenagers as cross-age teachers for younger youth
Study NCT03254303 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Difficulty of catheterization in group 60 s
Study NCT03254303 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Difficulty of catheterization in group 90 s
Study NCT03254303 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Difficulty of catheterization in group 120 s
Study NCT02410915 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hybrid Assistive Limb (HAL); gait training
Description: Training with HAL is performed in 1 session per day, 4 days per week during 4 weeks. Time for each session is individualised but does not exceed 60 minutes/session (effective time). Training with HAL is performed in combination with body-weight support system and on a treadmill. The training program is performed by 2 physiotherapists, who have been trained in the HAL method.
Study NCT02410915 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group; Conventional gait training
Description: Conventional gait training is individualized and performed according to current practice (approximately 30-60 minutes/session, 5 days a week) and may include standing, weight shifting, stepping, over ground walking with assistance and/or assistant devices as well as the use of a treadmill and body weight support. Conventional gait training is offered to both study groups.
Study NCT04493515 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Oxytocin
Description: Administration of oxytocin orally (24 IU)
Study NCT04493515 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oral Placebo
Description: Administration of placebo orally (24 IU)
Study NCT03970889 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Klue
Description: Klue is a software program the uses an Apple watch to detect hand motions which are indicative of eating.
Study NCT05807503 — intervention group
Intervention type: DRUG
Intervention: Cerebrolysin
Description: Cerebrolysin administration in short period of time after TBI
Study NCT02504203 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: BCG-Denmark 1331 (Statens Serum Institute)
Description: See above
Study NCT01792466 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transpancreatic sphincterotomy
Description: A sphinctertome will be placed into the pancreatic duct over a guidewire and the sphincter will be cut in the direction of the bile duct
Study NCT04416542 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Home Sleep Testing
Description: Two-night Home Sleep Tests (HSTs) will be conducted using commercially available Home Sleep Test equipment. The HST will be ordered by the clinical center through a HIPAA compliant HST service that has been selected by the study sponsor.~The HSTs will be scored and interpreted according to AASM Guidelines by board certified sleep physicians affiliated with the HST service. The HST will be scored using the 4% oxygen desaturation rule.
Study NCT01544114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VIMOVO 250/20
Description: 250 mg naproxen/20 mg esomeprazole magnesium oral tablet administered twice daily for up to 6 months
Study NCT01544114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VIMOVO 375/20
Description: 375 mg naproxen/20 mg esomeprazole magnesium oral tablet administered twice daily for up to 6 months
Study NCT02056132 — intervention group
Intervention type: OTHER
Intervention: Exhaled Breath Condensate
Description: Lab results of Exhaled Breath Condensate
Study NCT01899885 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: AHA (Acute Highrisk Abdominalsurgery): Optimized Course
Description: optimized course: Intervention before, during and after abdominal surgery.~Focus on fast track with multimodal standardized intervention:~1. standardized preparing for surgery including high dose antibiotics and epidural analgesia etc. and transfer to intermediate care before surgery (the post-anaesthesia care unit)~2. GDT-LiDCO fluid management pre-, per- and postoperative~3. Postoperative triage to 24 hour intermediate care based on ASA score and Surgical Apgar Score~4. Focus on early mobilization, fysiotherapy and optimal nutrition postoperatively
Study NCT03722888 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: smokeSCREEN video game
Description: smokeSCREEN video game is web-based videogame intervention focused on tobacco use prevention in teens. The game has 1.5-2 hours of unique game play and focuses on combustible cigarettes, e-cigarettes, and flavored tobacco products.smokeSCREEN. Guided by the social cognitive theory and the theory of planned behavior, smokeSCREEN addresses a range of challenges that teens often face involving peer pressure and the use of tobacco products. Participants are provided access to the smokeSCREEN game through a private, password-protected website link and instructed to complete the game.
Study NCT02411136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMG 623
Description: Multiple doses of AMG 623 administered as subcutaneous and intravenous doses
Study NCT01544114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VIMOVO 500/20
Description: 500 mg naproxen/20 mg esomeprazole magnesium oral tablet administered twice daily for up to 6 months
Study NCT02411136 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Multiple doses of AMG 623 administered as subcutaneous and intravenous doses
Study NCT02905864 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liraglutide 3 mg (Saxenda)
Study NCT02905864 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Liraglutide 3 mg placebo
Study NCT03982654 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bloomlife
Description: Women use the Bloomlife sensor to collect data throughout their pregnancy. The collected data is stored locally in the device, but it is not used to provide any feedback to the patients or to the clinical team. Therefore the use of the device doesn't have an impact on clinical decision making and patients' care.
Study NCT01658930 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radical Hysterectomy + pelvic lymph node dissection
Description: This procedure may be performed abdominally, laparoscopically, robotically or vaginally. The uterus, cervix, medial 1/3 of parametria, 2cm of the uterosacral ligaments and upper 1-2cm of the vagina are to be removed en bloc. The uterine artery is ligated laterally to the ureters and the ureters are unroofed to the ureterovesical junction.